ALOPESIA AREATA DENGAN TERAPI KOMBINASI INJEKSI PLATELET-RICH PLASMA (PRP) DAN TRIAMSINOLON ASETONID INTRALESI
DOI:
https://doi.org/10.33820/mdvi.v49i1.217Keywords:
alopesia areata, injeksi intralesi, triamsinolon asetonid, platelet-rich plasmaAbstract
Alopecia Areata (AA) is an autoimmune disease characterized by sudden hair loss from the scalp. Treatment of existing AA is difficult, so a combination of more than one therapeutic modality is needed. This is a case report of a 29-year-old man who complained of hair loss on the occipital and temporal right scalp, causing local baldness. Neither itching nor pain in the affected area. The patient was suffered from hair loss for the past two months. Based on anamnesis, physical examination, and other supporting examinations, the patient was diagnosed with AA. The management was given in the form of combination intralesional therapy and obtained a satisfactory result. Although the diagnosis of AA is quite easy, the treatment of AA tends to be difficult and remains a clinical challenge. This is due to the lack of randomized controlled trials for the management of AA and the psychological aspect of AA that can cause anxiety and depression. The combination therapy was given in the form of an intralesional injection of triamcinolone acetonide followed by an intralesional injection of platelet-rich plasma (PRP) at intervals of 3 weeks in each session. Satisfactory results are obtained after 5 months of combined intralesional therapy.
Downloads
References
2. Mubki T. Platelet-rich plasma combined with intralesional triamcinolone acetonide for the treatment of alopecia areata: A case report. J Dermatology Dermatologic Surg. 2016;20(1):87–90. Available from: http://dx.doi.org/10.1016/j.jdds.2015.11.002
3. Messenger AG, McKillop J, Farrant P, McDonagh AJ, Sladden M. British Association of Dermatologists’ guidelines for the management of alopecia areata 2012. Br J Dermatol. 2012;166(5):916–26.
4. Alessandrini A, Starace M, Bruni F, Brandi N, Baraldi C, Misciali C, dkk. Alopecia Areata Incognita and Diffuse Alopecia Areata: Clinical, Trichoscopic, Histopathological, and Therapeutic Features of a 5-Year Study. Dermatol Pract Concept. 2019;9(4):272–7.
5. Yeliur I, Tirumalae R. Histopathologic approach to alopecia. Indian J Dermatopathol Diagnostic Dermatology. 2018;5(2):79.
6. Li Y, Yan B, Wang H, Li H, Li Q, Zhao D, dkk. Hair regrowth in alopecia areata patients following Stem Cell Educator therapy. BMC Med. 2015;13(1):1–11.
7. Zhou C, Li X, Wang C, Zhang J. Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management. Clin Rev Allergy Immunol. 2-21;61:403–23. https://doi.org/10.1007/s12016-021-08883-0.
8. Pratt CH, King LE, Messenger AG, Christiano AM, Sundberg JP. Alopecia areata. Nat Rev Dis Prim. 2017;3:1–17.
9. Strazzulla LC, Wang EHC, Avila L, Lo Sicco K, Brinster N, Christiano AM, dkk. Alopecia areata: Disease characteristics, clinical evaluation, and new perspectives on pathogenesis. J Am Acad Dermatol. 2018;78(1):1–12.
10. Otberg N, Shapiro J. Alopecia Areata. Dalam: Kang S, Amagai M, Bruckner A, Enk A, Margolis D, McMichael A, dkk., penyunting. Fitzpatrick’s Dermatology 2. Edisi ke-9. New York: Mc Graw Hill; 2019. h. 1517–22.
11. Vidal CI. Overview of alopecia: a dermatopathologist’s perspective. Mo Med. 2015;112(4):308–12.
12. Marahatta S, Agrawal S, Adhikari BR. Psychological Impact of Alopecia Areata. Dermatol Res Pract 2020. https://doi.org/10.1155/2020/8879343.
13. Pratt CH, King LE, Messenger AG, Christiano AM, Sundberg JP. 2017. Alopecia areata. Nat Rev Dis Prim 3, 1–17. https://doi.org/10.1038/nrdp.2017.11.
14. Dainichi T, Kabashima K. Alopecia areata: What’s new in epidemiology, pathogenesis, diagnosis, and therapeutic options? J. Dermatol Sci. 2017;86:3–12. https://doi.org/10.1016/j.jdermsci.2016.10.004.
15. Tharumanathan S. Understanding the biological mechanism of alopecia areata. Am J Dermatol Venereol. 2015;4(1):1–4.
16. Lyakhovitsky A, Gilboa S, Eshkol A, Barzilai A, Baum S. Late-onset alopecia areata: A retrospective cohort study. Dermatology. 2018;233(4):289–94.
17. Jha A, Udayan U, Amar AK, Chaudhary R. Dermoscopy of alopecia areata in restrospective analysis. Dermatol Pract Concept. 2017;7(2):53–7.
18. Hall B, Cockerell C, Chisholm C, Jessup C, Vandergriff T, Motaparthi K, dkk. Alopecia Areata. Dalam: Nonneoplastic Dermatopathology. Edisi ke-2. Philadephia: Elsevier; 2017. h. 396–9.
19. Ratnaparkhi R, Tellez A, Piliang M, Bergfeld W. Eosinophilia versus atopy as a predictor of severe phenotypes in alopecia areata. J Am Acad Dermatol. 2016;74(5):AB135.
20. Muhaidat JM, Al-Qarqaz F, Khader Y, Alshiyab DM, Alkofahi H, Almalekh M. A retrospective comparative study of two concentrations of intralesional triamcinolone acetonide in the treatment of patchy alopecia areata on the scalp. Clin Cosmet Investig Dermatol. 2020;13:795–803.
21. Anitua E, Pino A, Jaén P, Navarro MR. Platelet-rich plasma for the management of hair loss: Better alone or in combination? J Cosmet Dermatol. 2019;18(2):483–6.
